Perceptive Advisors LLC Astria Therapeutics, Inc. Transaction History
Perceptive Advisors LLC
- $4.77 Billion
- Q1 2024
A detailed history of Perceptive Advisors LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 6,485,420 shares of ATXS stock, worth $59 Million. This represents 1.91% of its overall portfolio holdings.
Number of Shares
6,485,420
Previous 4,004,070
61.97%
Holding current value
$59 Million
Previous $30.8 Million
196.74%
% of portfolio
1.91%
Previous 0.75%
Shares
6 transactions
Others Institutions Holding ATXS
# of Institutions
122Shares Held
48.8MCall Options Held
3.59MPut Options Held
483K-
Tcg Crossover Management, LLC Palo Alto, CA5.28MShares$48 Million7.82% of portfolio
-
Vr Adviser, LLC New York, NY3.61MShares$32.8 Million4.36% of portfolio
-
Black Rock Inc. New York, NY3.59MShares$32.6 Million0.0% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$32.3 Million7.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$23.1 Million0.0% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $138M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...